trial

Real-Time Mobile Cognitive Behavioral Intervention for Serious Mental Illness

NCTId NCT02035202
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 255 (actual)
Sponsored by University of California Riverside at C.I. Trials, Inc.-Inland Empire
Primary completion 2017-05
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
255 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2013-10
Primary completion
2017-05
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
CBT2goSmartphone

Sponsors

University of California Riverside at C.I. Trials, Inc.-Inland EmpireLead Sponsor

Investigators

1
Colin Depp, PhDPrincipal Investigator

Sites

1 total
San Diego, United States

Facts & assertions

4 sourced
Enrollment
255
Phase
NA
Primary Completion Date
2017-05
Status
COMPLETED
relationships
The graph out of here
drug
CBT2go
drug
Smartphone
drug
lead_sponsor
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
indication
Schizophrenia
indication
Bipolar Disorder
indication
Bipolar Disorder
indication
investigator
Colin Depp, PhD
person